« Home

Home » Chemistry » Patrick: An Introduction to Medicinal Chemistry 4e » Student resources » Hyperlinked bibliography » Chapter 10

Patrick: An Introduction to Medicinal Chemistry 4e

Chapter 10

Further reading

Berg, C., Neumeyer, K., and Kirkpatrick, P. (2003) Teriparatide, Nature Reviews Drug Discovery, 2, 257-258 [DOI: 10.1038/nrd1068] [PubMed: 12680372].

Buolamwini, J. K., et al, (2005) Small molecule antagonists of the MDM2 oncoprotein as anticancer agents. Current Cancer Drug Targets, 5, 57-68 [DOI: 10.2174/1568009053332672].

Dwek, R. A., et al. (2002) Targeting glycosylation as a therapeutic approach. Nature Reviews Drug Discovery, 1, 65-75 [DOI: 10.1038/nrd708] [PubMed: 12119611].

Farina, V. (ed.). (1995) The chemistry and pharmacology of taxol and its derivatives. Elsevier, Amsterdam.

Le, G. T., et al. (2003) Molecular diversity through sugar scaffolds. Drug Discovery Today, 8, 701-709 [DOI: 10.1016/S1359-6446(03)02751-X].

Maeder, T. (2002) Sweet medicines. Scientific American, July, 24-31.

Ng, E. W. M., et al. (2006). Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nature Reviews Drug Discovery, 5, 123-132 [DOI: 10.1038/nrd1955] [PubMed: 16518379].

Ojima, I., et al. (2005) Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents. Journal of Medicinal Chemistry, 48, 2218-2228 [DOI: 10.1021/jm049483y] [PubMed: 15771464].

Shimogawa, H., et al. (2004) A wrench-shaped synthetic molecule that modulates a transcription factor-coactivator interaction, Journal of the American Chemical Society, 126, 3461-3471 [DOI: 10.1021/ja038855+] [PubMed: 15025473].

Toogood, P. L. (2002) Inhibition of protein-protein association by small molecules: approaches and progress. Journal of Medicinal Chemistry, 45, 1543-1558 [DOI: 10.1021/jm010468s] [PubMed: 11931608].

Vassilev, L. T. (2005) p53 Activation by small molecules: application in oncology. Journal of Medicinal Chemistry, 48, 4491-4499 [DOI: 10.1021/jm058174k] [PubMed: 15999986].

Wong, C. (2003) Carbohydrate-based drug discovery. John Wiley and Sons, Chichester.

Yin, H., et al. (2005) Terphenyl-based Bak BH3 α-helical proteomimetics as low-molecular-weight antagonists of Bcl-xl. Journal of the American Chemical Society, 127, 10191-10196 [DOI: 10.1021/ja050122x] [PubMed: 16028929].